- Home
- GRC vs GHRS Comparison
GRC vs GHRS Comparison
Compare GRC & GHRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GRC | GHRS |
|---|---|---|
| Founded | 1933 | 2018 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Fluid Controls | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.8B |
| IPO Year | 1994 | 2021 |
Fundamental Metrics
Financial Performance| Metric | GRC | GHRS |
|---|---|---|
| Price | $78.44 | $25.31 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 8 |
| Target Price | N/A | ★ $41.38 |
| AVG Volume (30 Days) | 212.3K | ★ 241.3K |
| Earning Date | 04-23-2026 | 05-01-2026 |
| Dividend Yield | ★ 1.04% | N/A |
| EPS Growth | ★ 32.03 | N/A |
| EPS | ★ 0.68 | N/A |
| Revenue | ★ $682,389,000.00 | N/A |
| Revenue This Year | $6.62 | N/A |
| Revenue Next Year | $4.66 | N/A |
| P/E Ratio | $116.91 | ★ N/A |
| Revenue Growth | ★ 3.44 | N/A |
| 52 Week Low | $36.41 | $11.32 |
| 52 Week High | $92.78 | $28.96 |
Technical Indicators
Market Signals| Indicator | GRC | GHRS |
|---|---|---|
| Relative Strength Index (RSI) | 42.34 | 52.72 |
| Support Level | $45.19 | $12.88 |
| Resistance Level | $79.02 | $25.30 |
| Average True Range (ATR) | 3.24 | 1.68 |
| MACD | -1.55 | -0.08 |
| Stochastic Oscillator | 11.05 | 51.70 |
Price Performance
Historical ComparisonAbout GRC Gorman-Rupp Company (The)
Gorman-Rupp Co designs, manufactures, and globally sells pumps & pump systems for use in water, wastewater, construction, dewatering, industrial, petroleum, original equipment, agriculture, fire protection, heating, ventilating & air conditioning, military, and other liquid-handling applications. It operates in one business segment, the manufacture & sale of pumps and pump systems, and generates revenue from the same. Geographically, it generates the majority of its revenue from the United States.
About GHRS GH Research PLC
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.